Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhenqi Fuzheng granules (ZQFZ) is a Traditional Chinese Medicine formulation composed of two main herbal ingredients: Astragali Radix (Astragalus membranaceus, or Huangqi) and Ligustri Lucidi Fructus (Fructus ligustri lucidi, or Nvzhenzi). [6, 8] This botanical product is primarily used as an adjuvant therapy in oncology to improve immunity, enhance the effectiveness of chemotherapy and radiotherapy, and reduce their adverse effects. [2] It has demonstrated immunomodulatory and anti-tumor effects, protecting bone marrow and adrenal cortex function while promoting the recovery of normal bodily functions. [2, 3] Studies suggest its mechanism involves multiple biological targets and pathways, including Interleukin-6 (IL-6), STAT3, EGFR, and TNF, as well as the PI3K-Akt and IL-17 signaling pathways. It also appears to modulate the NF-κB pathway and gut microflora. [8] The formulation is used for various conditions including non-small cell lung cancer (NSCLC), colorectal cancer, and general debility following illness or treatment. [1, 6, 8]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhenqi Fuzheng granules.